QY-1-T

N/A

Report date: 2024/03/14 17:26:14

Base Information

Drug NameQY-1-T
Drug Alias NameQY-1-T
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionHepatitis B virus inhibitors
TargetsHepatitis B virus
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesZhongke Qiyuan (Shenzhen) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiao Tong University Affiliated First People'S HospitalZhongke Qiyuan (Shenzhen) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A